Clinical trials
Parkinson’s disease clinical trials
A movement disorder caused by the loss of dopamine-producing brain cells. We’re tracking 739 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06540989RecruitingEarly Phase 1
Speech therapy with computer feedback for Parkinson's
This study tests a new speech therapy approach for people with Parkinson's disease who have mild to moderate speech problems. It uses a computer program that listens to your speech and helps you practice speaking more clearly.
New York, New YorkAges 50–80 - NCT06573762Recruiting
Home monitoring for Parkinson's disease
This study uses a Fitbit to track movement and symptoms from home. It is for people who are newly referred or recently diagnosed with Parkinson's disease.
Iowa City, IowaAges 50–110 - NCT06580977Recruiting
Exercise and memory in Parkinson's disease
This study tests whether a supervised exercise program can improve memory and thinking in people with Parkinson's disease. You may be able to join if you are between 50 and 80, have mild to moderate Parkinson's, and can walk independently.
Heidelberg, Baden-WurttembergAges 50–80 - NCT06582355Recruiting
Brain training with MRI for Parkinson's disease
This study tests whether a brain-training technique called neurofeedback can help people with Parkinson's disease. You will learn to control certain brain signals while having an MRI scan, which may improve your symptoms.
CologneAges 18 years+ - NCT06591975Recruiting
Upper extremity function and balance in Parkinson's disease
This study looks at how arm and hand function relates to balance and mobility in people with Parkinson's disease. Understanding this link may lead to better therapy approaches.
SivasAges 18–80 - NCT07381751Recruiting
AI assessment of Parkinson's motor symptoms via video
This study uses artificial intelligence to analyze videos of standard motor tests (MDS-UPDRS Part III) for people with Parkinson's disease. It aims to see if AI can reliably assess your symptoms, which could lead to easier, more accessible monitoring in the future.
Hong KongAges 18–95 - NCT07094269Recruiting
Fatigue management program for Parkinson's disease
This trial tests a structured fatigue management program compared to standard information to help people with Parkinson's disease better manage their energy. It aims to improve your confidence in using energy-saving strategies.
GenovaAges 18 years+ - NCT06605183Recruiting
Community walking program for Parkinson's disease
This study tests a 6-month community walking program designed for people with Parkinson's disease. It aims to help you stay active and improve your walking ability.
Las Vegas, NevadaAges 30–85 - NCT06629389RecruitingPhase 2
Cannabidiol (Kanbis) for Parkinson's symptoms
This trial tests whether cannabidiol (CBD) can help with Parkinson's disease symptoms. Researchers want to see if it's safe and effective for people with mild to moderate Parkinson's who are already on stable medications.
Mendoza, Mendoza ProvinceAges 40–80 - NCT06630702Recruiting
Spinal cord stimulation for freezing gait in advanced Parkinson's
This trial tests if a small device placed near your spine (spinal cord stimulation) can help improve freezing of gait in people with advanced Parkinson's whose medicines aren't enough. It also aims to reduce leg pain if you have it.
Hsinchu, Hsinchu CityAges 40–85 - NCT06646510Recruiting
Electrical stimulation for resting tremors in Parkinson's
This trial tests whether gentle electrical stimulation to the skin (called sensory electrical stimulation) can help reduce resting tremors in people with Parkinson's disease. Resting tremors are shaking that happens when your muscles are relaxed, like when your hands are in your lap.
GizaAges 45–60 - NCT06663826Recruiting
Digital diagnostic devices for Parkinson's disease
This study tests digital devices that may help track Parkinson's symptoms using eye movements and balance. It is designed for people with Parkinson's or related conditions who have trouble with walking (freezing) and can walk for at least 5 minutes.
Zurich, Canton of ZurichAges Any age - NCT06692920Recruiting
Parkinson's brain signals study during DBS surgery
This study looks at brain signals in people with Parkinson's who are already scheduled for Deep Brain Stimulation (DBS) surgery. The goal is to better understand how certain brain pathways work, which could lead to improved treatments.
Minneapolis, MinnesotaAges 21–75 - NCT06707402Recruiting
Community walking program for people with Parkinson's
This study tests whether a 24-week community walking program (brisk walking) can help people with Parkinson's disease who have trouble walking. If you join, you will walk regularly with others in your community and have your walking ability checked before and after.
Aarhus CAges 40 years+ - NCT07682532Recruiting
Theanine and Mediterranean diet for Parkinson's symptoms
This trial tests whether a supplement called L-theanine and a Mediterranean diet can improve sleep, digestion, and inflammation in early-stage Parkinson's disease. It may help if you are in stage 1 and live with a healthy partner.
IstanbulAges 50–80 - NCT07525973Enrolling by invitation
Eye Exercises to Help Parkinson's Disease Symptoms
This study tests whether simple eye exercises can help improve symptoms in people with Parkinson's disease. You'll do supervised eye exercises in a clinic to see if they help with movement, balance, or other Parkinson's symptoms.
IsfahanAges 18–80 - NCT06710574RecruitingPhase 4
Probiotics for sleep problems in Parkinson's disease
This study tests whether taking probiotics can improve REM sleep behavior disorder (RBD) in people with Parkinson's disease. You will receive either a probiotic supplement or a placebo, and researchers will use brain scans to see how it affects your symptoms.
BeijingAges 40–85 - NCT06719583Recruiting
Black and African Americans Connections to Parkinson's Disease
This study is building a research registry to learn more about how Parkinson's disease affects Black and African American communities. If you have Parkinson's or are a healthy volunteer, you can join by giving a saliva sample for genetic research.
Birmingham, AlabamaAges 18 years+ - NCT06732180RecruitingPhase 1
Testing a new drug (GT-02287) for Parkinson's disease
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
Darlinghurst, New South WalesAges 30–85 - NCT06751797Recruiting
Balance confidence and fear of falling in Parkinson's
This study looks at how confident people with Parkinson's are in their balance and whether fear of falling (kinesiophobia) affects their daily life. The goal is to better understand these factors so that future treatments can help people stay active and safe.
Istanbul, BeylikdüzüAges 50–80 - NCT06765668RecruitingPhase 4
Study of CREXONT for Parkinson's with wearing-off episodes
This study tests how well CREXONT, an extended-release form of carbidopa-levodopa, controls symptoms in people with Parkinson's who experience predictable 'off' periods when their regular medication wears off. The goal is to see if it can reduce the daily hours of poor mobility.
Phoenix, ArizonaAges 18 years+ - NCT06809400RecruitingPhase 1
Study of LY4006896 in healthy people and those with Parkinson's
This study tests an injectable antibody called LY4006896, first in healthy volunteers and then in people with Parkinson's disease. It aims to see if the drug is safe and how it works in the body.
Los Alamitos, CaliforniaAges 30–85 - NCT06834191Recruiting
Parkinson's and immunosuppressant drugs study
This study looks at how taking immunosuppressive medicines affects the course of Parkinson's disease. It compares people with Parkinson's who have been on these drugs for over a year to those who have never taken them regularly.
WarsawAges Any age - NCT06879821Recruiting
High-Intensity Exercise for Parkinson's: Brain and Body
This trial tests whether a high-intensity functional training program (a mix of strength, balance, and endurance exercises) can improve both physical movement and thinking skills in people with early-stage Parkinson's disease. You may qualify if you are in the early stages, exercise regularly, and can walk independently.
Valencia, ValenciaAges 40–80
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinson’s disease?
- Yes. Clin2 currently lists 739 recruiting parkinson’s disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson’s disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson’s disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.